Skip to main content
logo
Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
7.51
-0.07 (-0.92%)
At close: Mar 18, 2026, 4:00 PM EDT
7.75
+0.24 (3.20%)
After-hours: Mar 18, 2026, 7:19 PM EDT

Eupraxia Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-38.58-25.5-28.22-18.49-18.93
Depreciation & Amortization
0.240.170.160.150.09
Loss (Gain) From Sale of Assets
0-0.0200.01-
Stock-Based Compensation
8.763.221.411.432.71
Other Operating Activities
1.74-1.10.550.994.72
Change in Accounts Receivable
-0.43-0.1-0.10.230.15
Change in Accounts Payable
2.36-0.710.581.32-0.5
Change in Other Net Operating Assets
-2.64-5.954.88-0.040.05
Operating Cash Flow
-28.55-29.99-20.75-14.4-11.72
Capital Expenditures
-0.59-0.1-0.07-0.24-0.34
Sale of Property, Plant & Equipment
-0.03-0-
Investment in Securities
---10.07-7.11
Other Investing Activities
-----3.97
Investing Cash Flow
-0.59-0.08-0.079.83-11.42
Short-Term Debt Issued
----0.08
Long-Term Debt Issued
----10.08
Total Debt Issued
----10.16
Long-Term Debt Repaid
--9.14-0.08-0.14-0.46
Net Debt Issued (Repaid)
--9.14-0.08-0.149.69
Issuance of Common Stock
76.0654.9221.1610.9429.9
Financing Cash Flow
76.0645.7821.0810.839.59
Foreign Exchange Rate Adjustments
0.54-1.960.82-0.51-0.06
Net Cash Flow
47.4613.761.085.7316.39
Free Cash Flow
-29.14-30.1-20.82-14.63-12.06
Free Cash Flow Per Share
-0.73-0.89-0.86-0.76-0.97
Cash Interest Paid
-0.390.60.330.46
Levered Free Cash Flow
-16.3-20.95-10.78-8.72-12.98
Unlevered Free Cash Flow
-16.3-20.35-10.05-8.11-12.37
Change in Working Capital
-0.71-6.765.351.51-0.3
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q